Usa India Washington county St. Louis city Hyderabad covid-19 vaccine medicines Usa India Washington county St. Louis city Hyderabad

Intranasal COVID-19 vaccine: Bharat Biotech likely to start clinical trial soon

Reading now: 110
www.livemint.com

PTI. The Hyderabad-based pharma major has tied up with Washington University School of Medicine in St Louis to develop novel "chimp-adenovirus" (Chimpanzee adenovirus), a single doseintranasalvaccine for COVID-19.

Dubbed as BBV154, the preclinical trial of its intranasal COVID-19 vaccine was already completed for toxicology, immunogenicity and challenge studies."These studies have been conducted in the USA and India.

Phase I human clinical trials will commence during Feb-March, 2021," Bharat Biotech told PTI. The trial will be be conducted in India, Bharat Biotech added.

It will be held in Saint Louis University's Vaccine and Treatment Evaluation Unit, according to the news agency."The drugmaker is focusing on the intranasal vaccine as the.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA